search
Back to results

Pulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery

Primary Purpose

Knee Injuries, Shoulder Injuries, Pain, Postoperative

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Endonovo SofPulse
Sponsored by
Stanford University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Knee Injuries focused on measuring PEMF

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Subjects may be male or female greater or equal to 18 years of age (≥ 18) at the time of consent.
  2. Subjects who will be having shoulder or knee surgery are permitted.
  3. Subject must not have used NSAIDs for one (1) week prior to surgery.

    a. a. Low-dose aspirin (81 mg) is permitted.

  4. Subject must be willing and able to participate in post-operative physical therapy exercises.
  5. Subject must understand and be willing to sign the IRB-approved Informed Consent Document.

Exclusion Criteria:

  1. Subject has a known collagen disorder such as, but not limited to, osteogenesis imperfecta (OI) or Ehlers-Danlos syndrome (EDS).
  2. Subject has a known inflammatory or autoimmune connective tissue disease such as, but not limited to, gout affecting the shoulder, scleroderma, SLE, rheumatoid disease, or calcific tendonitis of the shoulder.
  3. Subject has a metabolic bone disease such as Paget's disease or osteomalacia as documented in the medical record.
  4. Subject has a deltoid defect, deltoid palsy or any other pseudoparalysis.
  5. Subject is diabetic.
  6. Subject has HIV or hepatitis.
  7. Subject has a diagnosis of fibromyalgia or other chronic pain syndrome.
  8. Subject has shoulder or knee pain of unknown etiology.
  9. Subject has had an active malignancy in the past 5 years OR has an active or on-going neoplastic disease, except for benign skin cancer(s).
  10. Subject has undergone administration, within 30 days prior to surgery, of any type of corticosteroid (with the exception of asthma medications and ophthalmic medications), antineoplastic, immunostimulation or immunosuppressive agent.
  11. Subject is septic, or has a local or systemic infection.
  12. Subject has an admitted active substance abuse problem which includes recreational drugs and/or narcotics or a history of substance abuse where history is defined as "not under the care of a physician" for more than 5 years.

    a. Prescriptive medical marijuana is not permitted, including CBD oils.

  13. Subject consumes more than 14 (men) or 7 (women) standard drinks (alcoholic units) per week where a drink equals a 12 oz. beer, or a 5 oz. glass of wine, or a 1.5 oz. shot of liquor.
  14. Subject is currently seeking or receiving worker's compensation for this injury or for an injury that has occurred more than 12 months prior to enrollment in this study or subjects who are currently in litigation or who have a history of litigation related to musculoskeletal diagnoses.
  15. Subject has major mental illnesses including major depression, bipolar disorder, schizophrenia or dementia that would prevent them from following the protocol and/or independently completing the patient reported outcomes measures.
  16. Subjects who have coexistent cervical spinal pathologies such as radiculopathies or myelopathies.
  17. Subject has a mental or physical condition that would prevent them from complying with the study protocol.

Sites / Locations

  • Stanford UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Active PEMF Group

Placebo PEMF Group

Arm Description

Participants will have a 1 in 2 chance to get the active treatment device post-operatively. The device will be attached to the post-operative dressing. The device is an Endonovo SofPulse that emits a pulsed electromagnetic field (PEMF). Single blind randomization.

Participants will have a 1 in 2 chance to get the placebo treatment device post-operatively. The device will be attached to the post-operative dressing. The Endonovo SofPulse placebo device does not emit a pulsed electromagnetic field (PEMF). Single blind randomization.

Outcomes

Primary Outcome Measures

Mean change from baseline in pain scores on the visual analog scale (VAS) at 10 days
The VAS is a subjective pain scale from 0 to 10, with 0 representing no pain.

Secondary Outcome Measures

Mean change from baseline in narcotic pain medicine use at 10 days
Pain medication will be documented every 24 hours.

Full Information

First Posted
September 27, 2019
Last Updated
July 11, 2022
Sponsor
Stanford University
Collaborators
Endonovo
search

1. Study Identification

Unique Protocol Identification Number
NCT04109638
Brief Title
Pulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery
Official Title
A Pilot Prospective, Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy in Decreasing Post-Operative Pain Following Orthopedic Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Recruiting
Study Start Date
February 1, 2021 (Actual)
Primary Completion Date
February 2024 (Anticipated)
Study Completion Date
February 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University
Collaborators
Endonovo

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary objective of this study is to prospectively determine, at 10 days after orthopedic shoulder or knee surgery, if pulsed electromagnetic field (PEMF) therapy is beneficial in reducing patient-reported post-operative pain, as measured by visual analog scale (VAS). The amount of pain medication taken daily and the physical function outcome scores after surgery and PEMF treatment will also be measured.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Injuries, Shoulder Injuries, Pain, Postoperative
Keywords
PEMF

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
76 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Active PEMF Group
Arm Type
Active Comparator
Arm Description
Participants will have a 1 in 2 chance to get the active treatment device post-operatively. The device will be attached to the post-operative dressing. The device is an Endonovo SofPulse that emits a pulsed electromagnetic field (PEMF). Single blind randomization.
Arm Title
Placebo PEMF Group
Arm Type
Sham Comparator
Arm Description
Participants will have a 1 in 2 chance to get the placebo treatment device post-operatively. The device will be attached to the post-operative dressing. The Endonovo SofPulse placebo device does not emit a pulsed electromagnetic field (PEMF). Single blind randomization.
Intervention Type
Device
Intervention Name(s)
Endonovo SofPulse
Other Intervention Name(s)
Endonovo tPEMF Device
Intervention Description
The active device emits PEMF signal whereas the placebo device does not emit a PEMF signal. The active device is on for 15 minutes at a time, every two hours, for 10 days.
Primary Outcome Measure Information:
Title
Mean change from baseline in pain scores on the visual analog scale (VAS) at 10 days
Description
The VAS is a subjective pain scale from 0 to 10, with 0 representing no pain.
Time Frame
10 days
Secondary Outcome Measure Information:
Title
Mean change from baseline in narcotic pain medicine use at 10 days
Description
Pain medication will be documented every 24 hours.
Time Frame
10 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects may be male or female greater or equal to 18 years of age (≥ 18) at the time of consent. Subjects who will be having shoulder or knee surgery are permitted. Subject must not have used NSAIDs for one (1) week prior to surgery. a. a. Low-dose aspirin (81 mg) is permitted. Subject must be willing and able to participate in post-operative physical therapy exercises. Subject must understand and be willing to sign the IRB-approved Informed Consent Document. Exclusion Criteria: Subject has a known collagen disorder such as, but not limited to, osteogenesis imperfecta (OI) or Ehlers-Danlos syndrome (EDS). Subject has a known inflammatory or autoimmune connective tissue disease such as, but not limited to, gout affecting the shoulder, scleroderma, SLE, rheumatoid disease, or calcific tendonitis of the shoulder. Subject has a metabolic bone disease such as Paget's disease or osteomalacia as documented in the medical record. Subject has a deltoid defect, deltoid palsy or any other pseudoparalysis. Subject is diabetic. Subject has HIV or hepatitis. Subject has a diagnosis of fibromyalgia or other chronic pain syndrome. Subject has shoulder or knee pain of unknown etiology. Subject has had an active malignancy in the past 5 years OR has an active or on-going neoplastic disease, except for benign skin cancer(s). Subject has undergone administration, within 30 days prior to surgery, of any type of corticosteroid (with the exception of asthma medications and ophthalmic medications), antineoplastic, immunostimulation or immunosuppressive agent. Subject is septic, or has a local or systemic infection. Subject has an admitted active substance abuse problem which includes recreational drugs and/or narcotics or a history of substance abuse where history is defined as "not under the care of a physician" for more than 5 years. a. Prescriptive medical marijuana is not permitted, including CBD oils. Subject consumes more than 14 (men) or 7 (women) standard drinks (alcoholic units) per week where a drink equals a 12 oz. beer, or a 5 oz. glass of wine, or a 1.5 oz. shot of liquor. Subject is currently seeking or receiving worker's compensation for this injury or for an injury that has occurred more than 12 months prior to enrollment in this study or subjects who are currently in litigation or who have a history of litigation related to musculoskeletal diagnoses. Subject has major mental illnesses including major depression, bipolar disorder, schizophrenia or dementia that would prevent them from following the protocol and/or independently completing the patient reported outcomes measures. Subjects who have coexistent cervical spinal pathologies such as radiculopathies or myelopathies. Subject has a mental or physical condition that would prevent them from complying with the study protocol.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michelle Xiao, BS
Phone
6507230003
Email
mxiao@stanford.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Geoffrey D Abrams, MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stanford University
City
Redwood City
State/Province
California
ZIP/Postal Code
94063
Country
United States
Individual Site Status
Recruiting

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Pulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery

We'll reach out to this number within 24 hrs